Skip to main content
. Author manuscript; available in PMC: 2010 Jul 6.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2008 Feb 22;17(3):525–534. doi: 10.1158/1055-9965.EPI-07-2704

Table 2.

Odds Ratios (ORs) and 95% Confidence Intervals (CIs) for Biliary Stones and Cancer in Relation to Polymorphisms of Lipid Metabolism Genes

Biliary Tract Cancers

Genotype Controls Biliary Stones 1 Gallbladder2 Bile duct3 Ampulla of Vater3



n (%) n (%) OR4 (95% CI)4 n (%) OR4 (95% CI)4 n (%) OR4 (95% CI)4 n (%) OR4 (95% CI)4




TOTAL 779 (100.0) 880 (100.0) -   -   235 (100.0) -   -   125 (100.0) -   -   46 (100.0) -   -  
APOE
    IVS1+69C>G (rs440446)
        CC 319 (41.4) 326 (37.4) 1.00 -   85 (36.8) 1.00 -   32 (25.8) 1.00 -   10 (21.7) 1.00 -  
        GC 355 (46.1) 425 (48.7) 1.25 (0.99–1.57)   113 (48.9) 1.21 (0.87–1.67)   72 (58.1) 2.01 (1.29–3.14)   24 (52.2) 2.09 (0.98–4.44)  
        GG 96 (12.5) 121 (13.9) 1.43 (1.01–2.02)   33 (14.3) 1.32 (0.83–2.10)   20 (16.1) 2.07 (1.13–3.79)   12 (26.1) 3.96 (1.66–9.46)  
        GC+GG 451 (58.6) 546 (62.6) 1.29 (1.03–1.60)   146 (63.2) 1.23 (0.91–1.67)   92 (74.2) 2.03 (1.32–3.11)   36 (78.3) 2.48 (1.21–5.08)  
                P 5 0.02 0.18 0.003 0.002
APOB
    EX26-3573T>C (rs676210)
        TT 439 (56.7) 474 (53.9) 1.00 -   137 (58.5) 1.00 -   63 (50.4) 1.00 -   26 (57.8) 1.00 -  
        TC 288 (37.2) 348 (39.6) 1.12 (0.89–1.40)   80 (34.2) 0.91 (0.66–1.25)   57 (45.6) 1.38 (0.94–2.04)   14 (31.1) 0.84 (0.43–1.64)  
        CC 47 (6.1) 57 (6.5) 1.02 (0.66–1.58)   17 (7.3) 1.15 (0.64–2.08)   5 (4.0) 0.74 (0.29–1.94)   5 (11.1) 1.89 (0.69–5.18)  
        TC+CC 335 (43.3) 405 (46.1) 1.10 (0.89–1.37)   97 (41.5) 0.94 (0.69–1.27)   62 (49.6) 1.30 (0.89–1.89)   19 (42.2) 0.99 (0.54–1.81)  
                 P 5 0.50 0.94 0.47 0.67
    IVS23-79T>C (rs673548)
        TT 407 (56.4) 446 (54.5) 1.00 -   129 (58.6) 1.00 -   59 (50.9) 1.00 -   26 (60.5) 1.00 -  
        TC 266 (36.9) 320 (39.1) 1.09 (0.86–1.37)   76 (34.5) 0.92 (0.66–1.27)   52 (44.8) 1.35 (0.90–2.02)   13 (30.2) 0.78 (0.40–1.56)  
        CC 48 (6.7) 53 (6.5) 0.92 (0.59–1.42)   15 (6.8) 0.97 (0.52–1.80)   5 (4.3) 0.72 (0.27–1.87)   4 (9.3) -   -  
        TC+CC 314 (40.6) 373 (45.5) 1.06 (0.85–1.32)   91 (41.4) 0.93 (0.68–1.26)   57 (49.1) 1.25 (0.85–1.86)   17 (39.5) 0.87 (0.46–1.63)  
                 P 5 0.86 0.69 0.60 0.62
    IVS6+360C>T (rs520354)
        CC 515 (67.2) 602 (69.6) 1.00 -   157 (67.1) 1.00 -   71 (57.7) 1.00 -   32 (69.6) 1.00 -  
        TC 234 (30.6) 242 (28.0) 0.82 (0.65–1.04)   69 (29.5) 0.93 (0.67–1.29)   46 (37.4) 1.41 (0.94–2.10)   14 (30.4) 0.96 (0.50–1.84)  
        TT 17 (2.2) 21 (2.4) 0.97 (0.48–1.95)   8 (3.4) 1.51 (0.63–3.60)   6 (4.9) 2.51 (0.96–6.57)   0 0 -   -  
        TC+TT 251 (32.8) 263 (30.4) 0.83 (0.66–1.05)   77 (32.9) 0.97 (0.71–1.33)   52 (42.3) 1.48 (1.01–2.18)   14 (30.4) 0.90 (0.47–1.71)  
                 P 5 0.15 0.95 0.02 0.74
    EX4+56C>T (rs1367117)
        CC 564 (73.6) 650 (75.3) 1.00 -   182 (78.1) 1.00 -   81 (65.9) 1.00 -   32 (71.1) 1.00 -  
        TC 192 (25.1) 195 (22.6) 0.84 (0.66–1.08)   43 (18.5) 0.68 (0.47–0.99)   40 (32.5) 1.44 (0.95–2.17)   12 (26.7) 1.13 (0.57–2.24)  
        TT 10 (1.3) 18 (2.1) 1.39 (0.61–3.17)   8 (3.4) 2.54 (0.97–6.70)   2 (1.6) -   -   1 (2.2) -   -  
        TC+TT 202 (26.4) 213 (24.7) 0.87 (0.69–1.11)   51 (21.9) 0.77 (0.54–1.09)   42 (34.1) 1.44 (0.96–2.15)   13 (28.9) 0.85 (0.65–1.10)  
                 P 5 0.44 0.44 0.08 0.67
LDLR
    IVS9-30C>T (rs1003723)
        CC 565 (72.6) 636 (72.6) 1.00 -   170 (72.3) 1.00 -   80 (64.5) 1.00 -   39 (84.8) 1.00 -  
        TC 199 (25.6) 223 (25.5) 0.98 (0.77–1.25)   61 (26.0) 1.02 (0.73–1.44)   39 (31.5) 1.38 (0.91–2.10)   7 (15.2) 0.50 (0.22–1.14)  
        TT 14 (1.8) 17 (1.9) 1.02 (0.47–2.22)   4 (1.7) -   -   5 (4.0) 2.53 (0.89–7.22)   0 0 -   -  
        TC+TT 213 (27.4) 240 (27.4) 0.98 (0.78–1.25)   65 (27.7) 1.02 (0.73–1.41)   44 (35.5) 1.46 (0.98–2.18)   7 (15.2) 0.47 (0.21–1.06)  
                 P 5 0.92 0.93 0.04 0.07
    EX10+55G>A (rs5927)
        GG 307 (39.9) 356 (41.0) 1.00 -   79 (33.9) 1.00 -   54 (43.2) 1.00 -   17 (37.0) 1.00 -  
        GA 348 (45.2) 382 (44.0) 0.94 (0.74–1.18)   120 (51.5) 1.34 (0.97–1.85)   52 (41.6) 0.85 (0.56–1.28)   17 (37.0) 0.88 (0.44–1.76)  
        AA 115 (14.9) 130 (15.0) 0.94 (0.68–1.30)   34 (14.6) 1.10 (0.70–1.74)   19 (15.2) 0.94 (0.53–1.65)   12 (26.0) 1.88 (0.87–4.07)  
        GA+AA 463 (60.1) 512 (59.0) 0.94 (0.75–1.17)   154 (66.1) 1.28 (0.95–1.75)   71 (56.8) 0.90 (0.61–1.32)   29 (63.0) 1.16 (0.63–2.15)  
                 P 5 0.62 0.35 0.66 0.18
    EX15-80G>A (rs14158)
        GG 696 (89.6) 794 (90.7) 1.00 -   204 (86.8) 1.00 -   114 (91.9) 1.00 -   42 (91.3) 1.00 -  
        GA 76 (9.8) 79 (9.0) 0.85 (0.59–1.22)   30 (12.8) 1.29 (0.82–2.02)   10 (8.1) 0.80 (0.40–1.60)   4 (8.7) 0.87 (0.30–2.49)  
        AA 5 (0.6) 2 (0.2) 0.30 (0.06–1.55)   1 (0.4) -   -   0 0 -   -   0 0 -   -  
        GA+AA 81 (10.4) 81 (9.3) 0.81 (0.57–1.15)   31 (13.2) 1.24 (0.80–1.94)   10 (8.1) 0.75 (0.38–1.50)   4 (8.7) 0.81 (0.28–2.31)  
                 P 5 0.16 0.33 0.42 0.70
    IVS17-42A>G (rs6413504)
        AA 411 (53.4) 448 (51.2) 1.00 -   120 (51.3) 1.00 -   59 (47.2) 1.00 -   25 (54.3) 1.00 -  
        GA 291 (37.8) 359 (41.0) 1.19 (0.95–1.49)   98 (41.9) 1.19 (0.87–1.62)   56 (44.8) 1.34 (0.90–1.99)   15 (32.6) 0.84 (0.43–1.62)  
        GG 67 (8.8) 68 (7.8) 0.94 (0.63–1.39)   16 (6.8) 0.81 (0.45–1.46)   10 (8.0) 1.04 (0.51–2.13)   6 (13.0) 1.42 (0.56–3.60)  
        GA+GG 358 (46.6) 427 (48.8) 1.14 (0.92–1.41)   114 (48.7) 1.12 (0.83–1.50)   66 (52.8) 1.28 (0.88–1.87)   21 (45.7) 0.95 (0.52–1.72)  
                 P 5 0.52 0.87 0.38 0.78
    EX18+88G>A (rs5930)
        GG 290 (37.5) 320 (36.7) 1.00 -   86 (36.9) 1.00 -   49 (39.5) 1.00 -   12 (26.1) 1.00 -  
        GA 364 (47.2) 416 (47.7) 1.05 (0.83–1.33)   108 (46.4) 1.01 (0.73–1.40)   56 (45.2) 0.91 (0.60–1.38)   21 (45.7) 1.38 (0.67–2.86)  
        AA 118 (15.3) 136 (15.6) 1.04 (0.75–1.44)   39 (16.7) 1.12 (0.72–1.73)   19 (15.3) 0.95 (0.54–1.69)   13 (28.3) 2.71 (1.19–6.12)  
        GA+AA 482 (62.4) 552 (63.3) 1.05 (0.84–1.31)   147 (63.1) 1.04 (0.76–1.41)   75 (60.5) 0.92 (0.62–1.36)   34 (73.9) 1.70 (0.87–3.34)  
                 P 5 0.74 0.66 0.78 0.02
LPL
    IVS5-540C>T (rs263)
        CC 485 (62.6) 539 (61.3) 1.00 -   151 (64.3) 1.00 -   79 (63.7) 1.00 -   28 (60.9) 1.00 -  
        TC 254 (32.8) 308 (35.0) 1.17 (0.93–1.47)   76 (32.3) 0.97 (0.71–1.34)   39 (31.5) 0.94 (0.62–1.42)   18 (39.1) 1.20 (0.65–2.21)  
        TT 36 (4.6) 32 (3.6) 0.68 (0.41–1.13)   8 (3.4) 0.69 (0.31–1.52)   6 (4.8) 1.02 (0.42–2.51)   0 0 -   -  
        TC+TT 290 (37.4) 340 (38.7) 1.10 (0.88–1.36)   84 (35.7) 0.94 (0.69–1.27)   45 (36.3) 0.95 (0.64–1.41)   18 (39.1) 1.05 (0.57–1.94)  
                 P 5 0.95 0.50 0.86 0.85
ALOX5
    IVS3+100G>A (rs2029253)
        GG 286 (37.0) 319 (36.4) 1.00 -   84 (35.9) 1.00 -   48 (38.7) 1.00 -   15 (32.6) 1.00 -  
        GA 376 (48.5) 432 (49.3) 1.09 (0.86–1.37)   113 (48.3) 1.05 (0.76–1.44)   60 (48.4) 0.95 (0.63–1.43)   25 (54.3) 1.24 (0.64–2.39)  
        AA 112 (14.5) 125 (14.3) 1.12 (0.80–1.57)   37 (15.8) 1.16 (0.74–1.82)   16 (12.9) 0.85 (0.46–1.56)   6 (13.0) 0.98 (0.37–2.59)  
        GA+AA 488 (63.1) 557 (63.6) 1.09 (0.88–1.36)   150 (64.1) 1.07 (0.79–1.46)   76 (61.3) 0.93 (0.63–1.37)   31 (67.4) 1.17 (0.62–2.22)  
                 P 5 0.43 0.53 0.60 0.85
1

Biliary stone cases include gallstone and bile duct stones. Biliary stone cases compared with controls without biliary stones (n=586)

2

Gallbadder cancer cases compared with population controls who had a gallbladder (n=730)

3

Bile duct and ampulla of Vater cancer cases compared to all population controls (n=779)

4

Adjusted for age

5

Test of trend for the number of copies of the variant allele (0,1,2);

Pearson chi-square for absence or presence of the variant allele if variant genotype has n < 5

Note: Total number of subjects per SNP may vary because of missing values